• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Current progress in immunotherapy of hepatocellular carcinoma.

作者信息

Sprinzl Martin F, Galle Peter R

机构信息

Department of Internal Medicine I, University Medical Center of the Johannes Gutenberg University Mainz, Germany.

Department of Internal Medicine I, University Medical Center of the Johannes Gutenberg University Mainz, Germany.

出版信息

J Hepatol. 2017 Mar;66(3):482-484. doi: 10.1016/j.jhep.2016.12.009. Epub 2016 Dec 21.

DOI:10.1016/j.jhep.2016.12.009
PMID:28011330
Abstract
摘要

相似文献

1
Current progress in immunotherapy of hepatocellular carcinoma.肝细胞癌免疫治疗的当前进展
J Hepatol. 2017 Mar;66(3):482-484. doi: 10.1016/j.jhep.2016.12.009. Epub 2016 Dec 21.
2
[Current status and progress of immunotherapy for hepatocellular carcinoma].
Zhonghua Gan Zang Bing Za Zhi. 2003 Dec;11(12):757.
3
Safety in treatment of hepatocellular carcinoma with immune checkpoint inhibitors as compared to melanoma and non-small cell lung cancer.免疫检查点抑制剂治疗肝细胞癌与黑色素瘤和非小细胞肺癌相比的安全性。
J Immunother Cancer. 2017 Nov 21;5(1):93. doi: 10.1186/s40425-017-0298-2.
4
Immunotherapy for Hepatocellular Carcinoma: Current Advances and Future Expectations.肝细胞癌的免疫治疗：当前进展与未来展望。
J Immunol Res. 2018 Mar 26;2018:8740976. doi: 10.1155/2018/8740976. eCollection 2018.
5
Perspectives of immunotherapy in hepatocellular carcinoma (HCC).肝细胞癌（HCC）免疫治疗的前景
Z Gastroenterol. 2016 Dec;54(12):1334-1342. doi: 10.1055/s-0042-120417. Epub 2016 Dec 9.
6
Immunotherapy for hepatocellular carcinoma.肝细胞癌的免疫疗法
Drug Discov Ther. 2015 Oct;9(5):363-71. doi: 10.5582/ddt.2015.01054.
7
Liver immunotolerance and hepatocellular carcinoma: Patho-physiological mechanisms and therapeutic perspectives.肝脏免疫耐受与肝细胞癌：病理生理机制及治疗前景
Eur J Cancer. 2017 Dec;87:101-112. doi: 10.1016/j.ejca.2017.10.010. Epub 2017 Nov 13.
8
Potentiality of immunotherapy against hepatocellular carcinoma.免疫疗法治疗肝细胞癌的潜力。
World J Gastroenterol. 2015 Sep 28;21(36):10314-26. doi: 10.3748/wjg.v21.i36.10314.
9
[Hepatocellular carcinoma - from immunobiology to immunotherapy].[肝细胞癌——从免疫生物学到免疫治疗]
Z Gastroenterol. 2012 Jan;50(1):47-56. doi: 10.1055/s-0031-1282002. Epub 2012 Jan 5.
10
Immunological landscape and immunotherapy of hepatocellular carcinoma.肝细胞癌的免疫景观和免疫疗法。
Nat Rev Gastroenterol Hepatol. 2015 Dec;12(12):681-700. doi: 10.1038/nrgastro.2015.173. Epub 2015 Oct 20.

引用本文的文献

1
Nanotechnology for the Diagnosis and Treatment of Liver Cancer.用于肝癌诊断与治疗的纳米技术
Int J Nanomedicine. 2024 Dec 24;19:13805-13821. doi: 10.2147/IJN.S490661. eCollection 2024.
2
New perspectives on chemokines in hepatocellular carcinoma therapy: a critical pathway for natural products regulation of the tumor microenvironment.探讨趋化因子在肝细胞癌治疗中的新视角：天然产物调控肿瘤微环境的关键途径。
Front Immunol. 2024 Aug 14;15:1456405. doi: 10.3389/fimmu.2024.1456405. eCollection 2024.
3
Biological impact and therapeutic implication of tumor-associated macrophages in hepatocellular carcinoma.
肿瘤相关巨噬细胞在肝细胞癌中的生物学影响和治疗意义。
Cell Death Dis. 2024 Jul 12;15(7):498. doi: 10.1038/s41419-024-06888-z.
4
Targeting LRRC41 as a potential therapeutic approach for hepatocellular carcinoma.将LRRC41作为肝细胞癌的一种潜在治疗方法。
Front Mol Biosci. 2023 Dec 21;10:1300294. doi: 10.3389/fmolb.2023.1300294. eCollection 2023.
5
A Comparative Study of Antitumor Immunity Induced by Radiofrequency Microwave and Cryoablation in Hepatocellular Carcinoma.射频微波与冷冻消融治疗肝癌的抗肿瘤免疫比较研究。
Appl Biochem Biotechnol. 2024 Jul;196(7):4088-4104. doi: 10.1007/s12010-023-04760-y. Epub 2023 Oct 27.
6
The Prognostic and Therapeutic Role of Histone Acetylation Modification in LIHC Development and Progression.组蛋白乙酰化修饰在肝癌发生发展中的预后和治疗作用。
Medicina (Kaunas). 2023 Sep 18;59(9):1682. doi: 10.3390/medicina59091682.
7
Combination therapy with dendritic cell loaded-exosomes supplemented with PD-1 inhibition at different time points have superior antitumor effect in hepatocellular carcinoma.在不同时间点联合使用负载树突状细胞的外泌体与 PD-1 抑制治疗，对肝癌具有更好的抗肿瘤效果。
Cancer Immunol Immunother. 2023 Nov;72(11):3727-3738. doi: 10.1007/s00262-023-03525-0. Epub 2023 Sep 4.
8
Immunogenic landscape and risk score prediction based on unfolded protein response (UPR)-related molecular subtypes in hepatocellular carcinoma.基于未折叠蛋白反应（UPR）相关分子亚型的肝细胞癌免疫原性景观和风险评分预测。
Front Immunol. 2023 Jun 30;14:1202324. doi: 10.3389/fimmu.2023.1202324. eCollection 2023.
9
Bioinformatics prediction and experimental verification identify cuproptosis-related lncRNA as prognosis biomarkers of hepatocellular carcinoma.生物信息学预测和实验验证确定铜死亡相关长链非编码RNA作为肝细胞癌的预后生物标志物。
Biochem Biophys Rep. 2023 Jun 21;35:101502. doi: 10.1016/j.bbrep.2023.101502. eCollection 2023 Sep.
10
Comprehensive analysis of prognostic value, relationship to cell cycle, immune infiltration and m6A modification of ZSCAN20 in hepatocellular carcinoma.全面分析 ZSCAN20 在肝细胞癌中的预后价值、与细胞周期的关系、免疫浸润和 m6A 修饰。
Aging (Albany NY). 2022 Dec 3;14(23):9550-9578. doi: 10.18632/aging.204312.